Dharmin Desai1, Ganesh Narayanasamy2, Milan Bimali3, Ivan Cordrey1, Hisham Elasmar1, Senthamizhchelvan Srinivasan1, Ellis Lee Johnson4. 1. Memorial Hospital, Chattanooga, TN, USA. 2. Department of Radiation Oncology, University of Arkansas for Medical Sciences, Little Rock, AR, USA. 3. Department of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, AR, USA. 4. Department of Radiation Medicine, University of Kentucky, Lexington, KY, USA.
Abstract
PURPOSE: To investigate a planning technique that can possibly reduce low-to-intermediate dose spillage (measured by R50%, D2cm values) in lung SBRT plans. MATERIALS AND METHODS: Dose falloff outside the target was studied retrospectively in 102 SBRT VMAT plans of lung tumor. Plans having R50% and/or D2cm higher than recommended tolerances in RTOG protocols 0813 and 0915 were replanned with new optimization constraints using novel shell structures and novel constraints. Violations in the RTOG R50% value can be rectified with a dose constraint to a novel shell structure ("OptiForR50"). The construction of structure OptiForR50% and the novel optimization criteria translate the RTOG goals for R50% into direct inputs for the optimizer. Violations in the D2cm can be rectified using constraints on a 0.5 cm thick shell structure with inner surface 2cm from the PTV surface. Wilcoxon signed-rank test was used to compare differences in dose conformity, volume of hot spots, R50%, D2cm of the target in addition to the OAR doses. A two-sided P-value of 0.05 was used to assess statistical significance. RESULTS: Among 102 lung SBRT plans with PTV sizes ranging from 5 to 179 cc, 32 plans with violations in R50% or D2cm were reoptimized. The mean reduction in R50% (4.68 vs 3.89) and D2cm (56.49 vs 52.51) was statistically significant both having P < 0.01. Target conformity index, volume of 105% isodose contour outside PTV, normal lung V20, and mean dose to heart and aorta were significantly lowered with P < 0.05. CONCLUSION: The novel planning methodology using multiple shells including the novel OptiForR50 shell with precisely calculated dimensions and optimizer constraints lead to significantly lower values of R50% and D2cm and lower dose spillage in lung SBRT plans. All plans were successfully brought into the zone of no RTOG violations.
PURPOSE: To investigate a planning technique that can possibly reduce low-to-intermediate dose spillage (measured by R50%, D2cm values) in lung SBRT plans. MATERIALS AND METHODS: Dose falloff outside the target was studied retrospectively in 102 SBRT VMAT plans of lung tumor. Plans having R50% and/or D2cm higher than recommended tolerances in RTOG protocols 0813 and 0915 were replanned with new optimization constraints using novel shell structures and novel constraints. Violations in the RTOG R50% value can be rectified with a dose constraint to a novel shell structure ("OptiForR50"). The construction of structure OptiForR50% and the novel optimization criteria translate the RTOG goals for R50% into direct inputs for the optimizer. Violations in the D2cm can be rectified using constraints on a 0.5 cm thick shell structure with inner surface 2cm from the PTV surface. Wilcoxon signed-rank test was used to compare differences in dose conformity, volume of hot spots, R50%, D2cm of the target in addition to the OAR doses. A two-sided P-value of 0.05 was used to assess statistical significance. RESULTS: Among 102 lung SBRT plans with PTV sizes ranging from 5 to 179 cc, 32 plans with violations in R50% or D2cm were reoptimized. The mean reduction in R50% (4.68 vs 3.89) and D2cm (56.49 vs 52.51) was statistically significant both having P < 0.01. Target conformity index, volume of 105% isodose contour outside PTV, normal lung V20, and mean dose to heart and aorta were significantly lowered with P < 0.05. CONCLUSION: The novel planning methodology using multiple shells including the novel OptiForR50 shell with precisely calculated dimensions and optimizer constraints lead to significantly lower values of R50% and D2cm and lower dose spillage in lung SBRT plans. All plans were successfully brought into the zone of no RTOG violations.
Authors: Linda X Hong; Viswanathan Shankar; Jin Shen; Hsiang-Chi Kuo; Dinesh Mynampati; Ravindra Yaparpalvi; Lee Goddard; Amar Basavatia; Jana Fox; Madhur Garg; Shalom Kalnicki; Wolfgang A Tomé Journal: Med Dosim Date: 2014-12-11 Impact factor: 1.482
Authors: Francesca Romana Giglioli; Stefania Clemente; Marco Esposito; Christian Fiandra; Carmelo Marino; Serenella Russo; Lidia Strigari; Elena Villaggi; Michele Stasi; Pietro Mancosu Journal: Phys Med Date: 2017-05-26 Impact factor: 2.685
Authors: Peng Dong; Percy Lee; Dan Ruan; Troy Long; Edwin Romeijn; Daniel A Low; Patrick Kupelian; John Abraham; Yingli Yang; Ke Sheng Journal: Int J Radiat Oncol Biol Phys Date: 2013-03-21 Impact factor: 7.038
Authors: Jean-Pierre Bissonnette; Kevin N Franks; Thomas G Purdie; Douglas J Moseley; Jan-Jakob Sonke; David A Jaffray; Laura A Dawson; Andrea Bezjak Journal: Int J Radiat Oncol Biol Phys Date: 2009-04-22 Impact factor: 7.038
Authors: Gregory M M Videtic; Chen Hu; Anurag K Singh; Joe Y Chang; William Parker; Kenneth R Olivier; Steven E Schild; Ritsuko Komaki; James J Urbanic; Robert D Timmerman; Hak Choy Journal: Int J Radiat Oncol Biol Phys Date: 2015-07-17 Impact factor: 7.038
Authors: Ganesh Narayanasamy; Dharmin Desai; Sanjay Maraboyina; Jose Penagaricano; Robert Zwicker; Ellis Lee Johnson Journal: J Med Phys Date: 2018 Jul-Sep